Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for XORTX Therapeutics Inc. (XRTX : NSDQ)

• Company Description    XORTX Therapeutics Inc. is a pharmaceutical therapeutics company. It focused on developing therapies to treat progressive kidney disease. XORTX Therapeutics Inc. is based in CALGARY, Alberta. Number of Employees: 15

• Price / Volume Information    Yesterday's Closing Price: $0.92 Daily Weekly Monthly 20 Day Moving Average: 1,607,447 shares Shares Outstanding: 1.82 (millions) Market Capitalization: $1.67 (millions) Beta: 0.78 52 Week High: $3.68 52 Week Low: $0.90 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -46.51% -45.94% 12 Week -54.45% -55.56% Year To Date -67.26% -69.20%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3710 - 33RD STREET NW - ALBERTA,A1 T2L 2M1 CAN ph: 403-455-7727 fax: - adavidoff@xortx.com http://www.xortx.com

• General Corporate Information    Officers Allen Davidoff - Chief Executive Officer and President Anthony J. Giovinazzo - Non-Executive Chair Michael Bumby - Chief Financial Officer William Farley - Director Abigail Jenkins - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 98420Q405 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/13/26 Share - Related Items Shares Outstanding: 1.82 Most Recent Split Date: 4.00 (0.20:1) Beta: 0.78 Market Capitalization: $1.67 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.30 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -10.53% vs. Previous Quarter: -81.03% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/26 - - 06/30/26 - -137.85 03/31/26 - -150.01 ROA 09/30/26 - - 06/30/26 - -108.16 03/31/26 - -106.53 Current Ratio 09/30/26 - - 06/30/26 - 3.58 03/31/26 - 0.86 Quick Ratio 09/30/26 - - 06/30/26 - 3.58 03/31/26 - 0.86 Operating Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Net Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Pre-Tax Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Book Value 09/30/26 - - 06/30/26 - 3.03 03/31/26 - 0.92 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00

Powered by Zacks Investment Research ©